Endocannabinoid system conceptual parameters, history and therapeutic possibilities

Main Article Content

Luis Henrique Almeida Castro
Geanlucas Mendes Monteiro
Ygor Thiago Cerqueira de Paula
Vanessa de Souza Ferraz
Flavia Soares Bezerra Okumoto Nery de Mello
Dayane Aparecida Moisés Caetano Bottini
Nelson Thiago Andrade Ferreira
Tayla Borges Lino
Juliana Vicente de Souza
Gildiney Penaves de Alencar
Wesley Sebastião da Silva Moraes
Fernanda Viana de Carvalho Moreto

Abstract

Among the drugs considered illicit in the West, the Cannabis sativa plant is the most consumed: around 4% of the adult population, 10% of these users are in a situation of dependence. However, the medicinal use of this herb dates back to the early days of the emergence of our own species: some anthropologists theorize that some of the genus Homo has progressed in the struggle for survival with other hominids precisely because of the advanced knowledge – kept to the proper proportions – it possessed of plants like Cannabis. Millennia later, science – even focusing intensely on the chemical characterization of its more than 530 bioactive components – was still not able to generate verifiable hypotheses in order to explain two of the most remarkable characteristics of the recreational use of this plant: because small chemical changes potentiated the effect of the drug up to 100 times and, mainly, because it would be virtually impossible for an individual to suffer a lethal overdose of the substance. To overcome this paradigm, some compounds derived from delta-ninetetrahydrocannabinol (Δ9-THC) - the main component of cannabis – were radioactively marked in an experimental study and, after their induction, it was discovered that they had tropism by brain membranes and that their binding was saturated and stereosleptic. Such evidence strongly suggested the existence of endogenous receptors for the drug and it was these findings that led to the discovery of the Endocanabinoid System (SEC): a physiological apparatus made up of endogenous receptors and binders, philogenetically conserved, responsible for several controls related to neuronal homeostasis.

Downloads

Download data is not yet available.

Article Details

How to Cite
Almeida Castro, L. H., Mendes Monteiro, G., Cerqueira de Paula, Y. T., de Souza Ferraz, V., Soares Bezerra Okumoto Nery de Mello, F., Aparecida Moisés Caetano Bottini, D., Andrade Ferreira, N. T., Borges Lino, T., Vicente de Souza, J., Penaves de Alencar, G., da Silva Moraes, W. S., & Viana de Carvalho Moreto, F. (2020). Endocannabinoid system: conceptual parameters, history and therapeutic possibilities. International Journal for Innovation Education and Research, 8(9), 354-358. https://doi.org/10.31686/ijier.vol8.iss9.2642
Section
Articles
Author Biography

Luis Henrique Almeida Castro, Federal University of Grande Dourados

PhD in the Health Sciences Graduate Program

References

Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol. 1999;58(4):315-48.

Bonfa L, Vinagre RC, de Figueiredo NV. Cannabinoids in chronic pain and palliative care. Rev Bras Anestesiol, 2008;58(3):267-79. English, Portuguese.

Cooper ZD, Haney M. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol. 2008;13(2):188-95.

Dennis M, Babor TF, Roebuck MC, Donaldson J. Changing the focus: the case for recognizing and treating Cannabis use disorders. Addiction. 2002;97(Suppl 1):4-15.

Di Marzo V, Bisogno T, De Petrocellis L. Endocannabinoids: new targets for drug development. Curr Pharm Des. 2000;6(13):1361-80.

Fattore L, Fadda P, Spano MS, Pistis M, Fratta W. Neurobiological mechanisms of cannabinoid addiction. Mol Cell Endocrinol. 2008;286(1-2 Suppl 1):S97-107.

Hazekamp A. Medicinal use of Cannabis: a review. Leiden, The Netherlands: Leiden University, Department of Plant Metabolomics; 2008.

Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462.

Vandrey R, Haney M. Pharmacotherapy for Cannabis dependence: how close are we? CNS Drugs. 2009;23(7):543-53.

Zuardi AW. History of Cannabis as a medicine: a review. Rev Bras Psiquiatr. 2006; 28(2):153-7.

Most read articles by the same author(s)